Wednesday, 10 August 2022

HiMedia receives CE-IVD approval for Hi-PCR COVID-FLU Multiplex Probe PCR Kit

05 August 2022 | News

A multiplex PCR kit that can differentiate between COVID-19 and flu using a single tube reaction

HiGenoMB Molecular Biology Division of Mumbai-based HiMedia Laboratories adds another feather in the cap with their newly CE/IVD approved Hi-PCR COVID-FLU Multiplex Probe PCR Kit (MBPCR262). Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19.    

Hi-PCR COVID-FLU Multiplex Probe PCR Kit is a multiplex PCR kit that can differentiate between COVID-19 and Flu using a single tube reaction. It is recommended for sensitive and specific detection of SARS-CoV-2 and Influenza virus in clinical samples. Targets include RdRp gene of SARS-CoV-2 virus, Influenza A virus (Swine flu 2009 H1N1 virus, seasonal H3N2 & seasonal H1N1), Influenza B virus and Internal control (IC)

As the public's concern of contracting COVID-19 continued to rise, flu symptoms were frequently mistaken for those of COVID-19. Performing separate tests for detection of COVID-19 and Influenza can be time consuming, costly and a cumbersome affair. HiMedia’s MBPCR262 being a multiplex kit eliminates the need for separate tests thereby significantly reducing the time and resources.


Dr Kavita Khadke, Director of HiMedia’s Molecular Biology Division (HiGenoMB) says, ‘’An early diagnostic tool will help to differentiate between flu and COVID-19 was the need of the hour."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account